Edition:
United States

People: Genomic Health Inc (GHDX.O)

GHDX.O on Nasdaq

30.81USD
9 Dec 2016
Change (% chg)

$-0.17 (-0.55%)
Prev Close
$30.98
Open
$31.00
Day's High
$31.20
Day's Low
$30.70
Volume
117,994
Avg. Vol
209,438
52-wk High
$35.79
52-wk Low
$22.00

Baker, Felix 

Dr. Felix J. Baker, Ph.D., is appointed as the Director of Genomic Health, Inc. Dr. Baker's firm manages long-term investment funds, focused on publicly traded life sciences companies, for major university endowments and foundations. Dr. Baker's career as a fund-manager began in 1994 when he co-founded a biotechnology investing partnership with the Tisch Family. Dr. Baker is also a director of Seattle Genetics, Inc., where he serves as lead independent director, and serves as the Chairman of the Board of Synageva, Inc. Dr. Baker served as a director of Ardea Biosciences, Inc. from February 2010 until its acquisition in June 2012, and a director of Trimeris, Inc. from April 2004 until November 2011.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --